Jefferies Group LLC Biogen Inc. Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

A detailed history of Jefferies Group LLC transactions in Biogen Inc. stock. As of the latest transaction made, Jefferies Group LLC holds 50 shares of BIIB stock, worth $7,610. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 57,599 99.91%

Holding current value

$7,610

Previous $11.7 Million 99.89%

% of portfolio

0.0%

Previous 0.12%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Sep 21, 2023	SELL	$194.69 - $268.46 $11.2 Million - $15.4 Million	-57,549 Reduced 99.91%	50 $13,000
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $11.2 Million - $15.4 Million	-57,549 Reduced 99.91%	50 $13,000
Q2 2022 Sep 21, 2023	BUY	$187.54 - $223.02 $6.14 Million - $7.31 Million	32,760 Added 131.89%	57,599 $11.7 Million
Q2 2022 Aug 15, 2022	BUY	$187.54 - $223.02 $6.14 Million - $7.31 Million	32,760 Added 131.89%	57,599 $11.7 Million
Q1 2022 Sep 21, 2023	SELL	$193.77 - $244.14 $7.57 Million - $9.54 Million	-39,059 Reduced 61.13%	24,839 $5.23 Million
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $8.51 Million - $10.7 Million	-43,895 Reduced 63.86%	24,839 $5.23 Million
Q4 2021 Sep 21, 2023	BUY	$223.92 - $287.77 $12.2 Million - $15.7 Million	54,541 Added 582.89%	63,898 $15.3 Million
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $13.3 Million - $17.1 Million	59,377 Added 634.57%	68,734 $15.9 Million
Q3 2021 Sep 21, 2023	SELL	$282.99 - $369.05 $2.07 Million - $2.7 Million	-7,306 Reduced 43.85%	9,357 $2.65 Million
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $2.07 Million - $2.7 Million	-7,306 Reduced 43.85%	9,357 $2.65 Million
Q2 2021 Sep 21, 2023	SELL	$259.0 - $414.71 $14.5 Million - $23.2 Million	-55,843 Reduced 77.02%	16,663 $5.77 Million
Q2 2021 Aug 16, 2021	SELL	$259.0 - $414.71 $14.5 Million - $23.2 Million	-55,843 Reduced 77.02%	16,663 $5.77 Million
Q1 2021 Sep 21, 2023	BUY	$242.95 - $284.63 $16.7 Million - $19.6 Million	68,854 Added 1885.38%	72,506 $20.3 Million
Q1 2021 May 14, 2021	BUY	$242.95 - $284.63 $16.7 Million - $19.6 Million	68,854 Added 1885.38%	72,506 $20.3 Million
Q4 2020 Sep 21, 2023	BUY	$236.26 - $355.63 $851,008 - $1.28 Million	3,602 Added 7204.0%	3,652 $894,000
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $23,153 - $34,851	-98 Reduced 2.61%	3,652 $894,000
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $3.79 Million - $5.02 Million	-14,667 Reduced 79.64%	3,750 $1 Million
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $15.8 Million - $20 Million	-58,750 Reduced 76.13%	18,417 $5.83 Million
Q4 2019 Feb 13, 2020	BUY	$220.06 - $304.07 $9.03 Million - $12.5 Million	41,019 Added 113.48%	77,167 $22.9 Million
Q3 2019 Nov 13, 2019	SELL	$217.44 - $243.88 $252,882 - $283,632	-1,163 Reduced 3.12%	36,148 $8.42 Million
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $4.55 Million - $5.01 Million	20,727 Added 124.98%	37,311 $8.73 Million
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $3.25 Million - $5.08 Million	14,977 Added 931.99%	16,584 $3.92 Million
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $5.39 Million - $6.83 Million	-19,364 Reduced 92.34%	1,607 $484,000
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $4.08 Million - $5.34 Million	13,907 Added 196.87%	20,971 $7.41 Million
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $1.19 Million - $1.41 Million	-4,607 Reduced 39.47%	7,064 $2.05 Million
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $2.23 Million - $3.15 Million	8,558 Added 274.91%	11,671 $3.2 Million
Q4 2017 Feb 14, 2018	SELL	$307.64 - $344.58 $5.73 Million - $6.42 Million	-18,617 Reduced 85.67%	3,113 $992,000
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $6.11 Million - $7.16 Million	21,730	21,730 $6.8 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.9B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Account

Jefferies Group LLC Biogen Inc. Transaction History